Monthly Archives: September 2023

Sosei Group Corporation's (Sosei Heptares') PIVLAZ (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in...

AbbVie has announced a definitive agreement to acquire Cerevel Therapeutics and its neuroscience pipeline of multiple clinical-stage and preclinical candidates with potential across several...

Absci Corporation is collaborating with AstraZeneca to deliver an AI-designed antibody against an oncology target. The collaboration combines Absci’s Integrated Drug Creation platform with AstraZeneca’s...